HighTower Advisors’s Bio-Path Holdings Inc BPTH Stock Holding History
Bought
Maintained
Sold
Other funds holding BPTH
UOTTAIMCU
RCA
LTFS
TSS
HighTower Advisors's BPTH Position: Q4 2018 in Review
HighTower Advisors sold out of Bio-Path Holdings Inc (BPTH) in Q4 2018, closing a stake of 43 shares — an estimated $10K sold.
HighTower Advisors first reported a position in BPTH in Q1 2014 and held it in 18 quarters. The position peaked at $2.96M in Q1 2016. 17 funds tracked by Wall St. Rank hold BPTH as of Q4 2018.
- HighTower Advisors reported no remaining Bio-Path Holdings Inc position as of Q4 2018 after selling out during the quarter.
- HighTower Advisors sold 43 Bio-Path Holdings Inc shares in Q4 2018, an estimated $10K.
- HighTower Advisors first reported a position in Bio-Path Holdings Inc in Q1 2014 and held it in 18 quarters.
- HighTower Advisors's Bio-Path Holdings Inc position peaked at $2.96M in Q1 2016.
- 17 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2018.
Based on HighTower Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.